27357626|t|Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma
27357626|a|Adoptive T-cell transfer is a promising treatment approach for metastatic cancer, but efficacy in solid tumors has only been achieved with toxic pre- and postconditioning regimens. Thus, adoptive T-cell therapies would benefit from complementary modalities that enable their full potential without excessive toxicity. We aimed to improve the efficacy and safety of adoptive T-cell transfer by using adenoviral vectors for direct delivery of immunomodulatory murine cytokines into B16.OVA melanoma tumors with concomitant T-cell receptor transgenic OT-I T-cell transfer. Armed adenoviruses expressed high local and low systemic levels of cytokine when injected into B16.OVA tumors, suggesting safety of virus-mediated cytokine delivery. Antitumor efficacy was significantly enhanced with adenoviruses coding for murine interleukin-2 (mIL-2) and tumor necrosis factor-α (mTNFα) when compared with T-cell transfer alone or viruses alone. Further improvement in efficacy was achieved with a triple combination of mIL-2, mTNFα, and OT-I T-cells. Mechanistic studies suggest that mIL-2 has an important role in activating T-cells at the tumor, while mTNFα induces chemokine expression. Furthermore, adenovirus treatments enhanced tumor - infiltration of OT-I T-cells as demonstrated by SPECT/CT imaging of (111)In-labeled cells. Our results suggest the utility of cytokine-coding adenoviruses for improving the efficacy of adoptive T-cell therapies.
27357626	0	10	Adenoviral	T005	UMLS:C0001483
27357626	11	19	Delivery	T058	UMLS:C0011209
27357626	23	46	Tumor Necrosis Factor-α	T103	UMLS:C1456820
27357626	51	64	Interleukin-2	T103	UMLS:C0021756
27357626	84	105	Adoptive Cell Therapy	T058	UMLS:C0079613
27357626	109	126	Immunosuppressive	T103	UMLS:C0021081
27357626	127	135	Melanoma	T038	UMLS:C0025202
27357626	136	160	Adoptive T-cell transfer	T058	UMLS:C0376517
27357626	199	216	metastatic cancer	T038	UMLS:C0027627
27357626	234	246	solid tumors	T038	UMLS:C0280100
27357626	323	348	adoptive T-cell therapies	T058	UMLS:C0079613
27357626	501	525	adoptive T-cell transfer	T058	UMLS:C0376517
27357626	535	553	adenoviral vectors	T103	UMLS:C1510800
27357626	577	593	immunomodulatory	T058	UMLS:C1963758
27357626	594	600	murine	T204	UMLS:C0026809
27357626	601	610	cytokines	T103	UMLS:C0079189
27357626	616	623	B16.OVA	T017	UMLS:C0029974
27357626	624	639	melanoma tumors	T038	UMLS:C0004565
27357626	633	639	tumors	T038	UMLS:C0027651
27357626	657	672	T-cell receptor	T103	UMLS:C0034790
27357626	673	688	transgenic OT-I	T204	UMLS:C0025936
27357626	673	704	transgenic OT-I T-cell transfer	T058	UMLS:C0376517
27357626	712	724	adenoviruses	T005	UMLS:C0001483
27357626	773	781	cytokine	T103	UMLS:C0079189
27357626	801	808	B16.OVA	T017	UMLS:C0029974
27357626	809	815	tumors	T038	UMLS:C0027651
27357626	838	852	virus-mediated	T005	UMLS:C0042776
27357626	838	870	virus-mediated cytokine delivery	T058	UMLS:C0011209
27357626	853	861	cytokine	T103	UMLS:C0079189
27357626	923	935	adenoviruses	T005	UMLS:C0001483
27357626	947	953	murine	T204	UMLS:C0026809
27357626	954	967	interleukin-2	T103	UMLS:C0021756
27357626	969	974	mIL-2	T103	UMLS:C0021756
27357626	980	1003	tumor necrosis factor-α	T103	UMLS:C1456820
27357626	1005	1010	mTNFα	T103	UMLS:C1456820
27357626	1031	1046	T-cell transfer	T058	UMLS:C0376517
27357626	1056	1063	viruses	T005	UMLS:C0042776
27357626	1145	1150	mIL-2	T103	UMLS:C0021756
27357626	1152	1157	mTNFα	T103	UMLS:C1456820
27357626	1163	1175	OT-I T-cells	T017	UMLS:C0039194
27357626	1210	1215	mIL-2	T103	UMLS:C0021756
27357626	1252	1259	T-cells	T017	UMLS:C0039194
27357626	1267	1272	tumor	T038	UMLS:C0027651
27357626	1280	1285	mTNFα	T103	UMLS:C0041368
27357626	1294	1303	chemokine	T103	UMLS:C0282554
27357626	1304	1314	expression	T038	UMLS:C1171362
27357626	1329	1339	adenovirus	T005	UMLS:C0001483
27357626	1340	1350	treatments	T058	UMLS:C0087111
27357626	1360	1365	tumor	T038	UMLS:C0027651
27357626	1384	1396	OT-I T-cells	T017	UMLS:C0039194
27357626	1416	1432	SPECT/CT imaging	T058	UMLS:C3472245
27357626	1436	1457	(111)In-labeled cells	T017	UMLS:C0007634
27357626	1494	1509	cytokine-coding	T103	UMLS:C0079189
27357626	1510	1522	adenoviruses	T005	UMLS:C0001483
27357626	1553	1578	adoptive T-cell therapies	T058	UMLS:C0079613